Adiponectin deficiency drives cerebrovascular dysfunction and synergizes with amyloid-β to exacerbate alzheimer's pathology.

Zou W, Yick LW, Kwan JS, Zhang Z, Xue H, Chan KH

Open source

DOI
10.1186/s13195-026-01968-y
Published
2026 Jan 29
Container
Alzheimer's research & therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13195-026-01968-y,
  title = {Adiponectin deficiency drives cerebrovascular dysfunction and synergizes with amyloid-β to exacerbate alzheimer's pathology.},
  author = {Zou W and Yick LW and Kwan JS and Zhang Z and Xue H and Chan KH},
  year = {2026},
  journal = {Alzheimer's research \& therapy},
  doi = {10.1186/s13195-026-01968-y},
  url = {https://doi.org/10.1186/s13195-026-01968-y}
}

RIS

TY  - JOUR
TI  - Adiponectin deficiency drives cerebrovascular dysfunction and synergizes with amyloid-β to exacerbate alzheimer's pathology.
AU  - Zou W
AU  - Yick LW
AU  - Kwan JS
AU  - Zhang Z
AU  - Xue H
AU  - Chan KH
PY  - 2026
JO  - Alzheimer's research & therapy
DO  - 10.1186/s13195-026-01968-y
UR  - https://doi.org/10.1186/s13195-026-01968-y
ER  - 

APA

W, Z., LW, Y., JS, K., Z, Z., H, X., & KH, C. (2026). Adiponectin deficiency drives cerebrovascular dysfunction and synergizes with amyloid-β to exacerbate alzheimer's pathology.. Alzheimer's research & therapy. https://doi.org/10.1186/s13195-026-01968-y

Source records